Trial Outcomes & Findings for App-based Education and GOal-setting in Rheumatoid Arthritis (NCT NCT05888181)

NCT ID: NCT05888181

Last Updated: 2025-05-16

Results Overview

Superiority outcome. The ASES is a patient-reported questionnaire consisting of 20 items across 2 subscales: self-efficacy for managing pain (range 5-50), and self-efficacy for controlling other symptoms (range 6-60). Both scores can be summed to derive a total ASES-score (range 11-110). Higher scores indicate higher perceived self-efficacy.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

128 participants

Primary outcome timeframe

At follow-up visit (4-6 months from baseline)

Results posted on

2025-05-16

Participant Flow

Of 128 enrolled participants, 122 completed the necessary baseline assessments and installed the study app. These were entered in the ITT population.

Participant milestones

Participant milestones
Measure
Intervention Group A (Weekly RAID)
Access to the study app with weekly prompts to complete the patient-reported questionnaire Rheumatoid Arthritis Impact of Disease (RAID) Mobile app-based self-management intervention: The self-management program, accessible via a smartphone app, comprises several components. First, the app contains an RA-specific educational program presented as videos in 16 weekly modules. Second, the app provides patients with tailored lifestyle advice, both as part of the educational program and in the form of personalized messages from a certified health coach. Third, the study app includes remote monitoring features underpinned by goal-setting principles. For instance, participants can use the app to log daily steps and physical activity, as well as their diet, sleep, and mental health. Personal goals, as well as physical challenges and meditation or mindfulness exercises, can be set up within the app to encourage behavioral change. Finally, patient-reported disease burden can be monitored within the study app via the RAID instrument. Based on random allocation to one of both intervention groups, the RAID will be prompted either weekly (group A) or monthly (group B).
Intervention Group B (Monthly RAID)
Access to the study app with monthly prompts to complete the patient-reported questionnaire Rheumatoid Arthritis Impact of Disease (RAID) Mobile app-based self-management intervention: The self-management program, accessible via a smartphone app, comprises several components. First, the app contains an RA-specific educational program presented as videos in 16 weekly modules. Second, the app provides patients with tailored lifestyle advice, both as part of the educational program and in the form of personalized messages from a certified health coach. Third, the study app includes remote monitoring features underpinned by goal-setting principles. For instance, participants can use the app to log daily steps and physical activity, as well as their diet, sleep, and mental health. Personal goals, as well as physical challenges and meditation or mindfulness exercises, can be set up within the app to encourage behavioral change. Finally, patient-reported disease burden can be monitored within the study app via the RAID instrument. Based on random allocation to one of both intervention groups, the RAID will be prompted either weekly (group A) or monthly (group B).
Control Group (Usual Care)
No access to the study app, follow-up according to usual care standards. This includes informal screening for general wellbeing during outpatient clinic visits, with referral to specific allied health professionals for additional education or non-pharmacological support if needed. The scores derived from study-related questionnaires can be used as a guide for these discussions. As part of standard care, participants in both the control group and the intervention groups will also receive a standardised educational leaflet about RA.
Overall Study
STARTED
30
30
62
Overall Study
COMPLETED
29
29
62
Overall Study
NOT COMPLETED
1
1
0

Reasons for withdrawal

Reasons for withdrawal
Measure
Intervention Group A (Weekly RAID)
Access to the study app with weekly prompts to complete the patient-reported questionnaire Rheumatoid Arthritis Impact of Disease (RAID) Mobile app-based self-management intervention: The self-management program, accessible via a smartphone app, comprises several components. First, the app contains an RA-specific educational program presented as videos in 16 weekly modules. Second, the app provides patients with tailored lifestyle advice, both as part of the educational program and in the form of personalized messages from a certified health coach. Third, the study app includes remote monitoring features underpinned by goal-setting principles. For instance, participants can use the app to log daily steps and physical activity, as well as their diet, sleep, and mental health. Personal goals, as well as physical challenges and meditation or mindfulness exercises, can be set up within the app to encourage behavioral change. Finally, patient-reported disease burden can be monitored within the study app via the RAID instrument. Based on random allocation to one of both intervention groups, the RAID will be prompted either weekly (group A) or monthly (group B).
Intervention Group B (Monthly RAID)
Access to the study app with monthly prompts to complete the patient-reported questionnaire Rheumatoid Arthritis Impact of Disease (RAID) Mobile app-based self-management intervention: The self-management program, accessible via a smartphone app, comprises several components. First, the app contains an RA-specific educational program presented as videos in 16 weekly modules. Second, the app provides patients with tailored lifestyle advice, both as part of the educational program and in the form of personalized messages from a certified health coach. Third, the study app includes remote monitoring features underpinned by goal-setting principles. For instance, participants can use the app to log daily steps and physical activity, as well as their diet, sleep, and mental health. Personal goals, as well as physical challenges and meditation or mindfulness exercises, can be set up within the app to encourage behavioral change. Finally, patient-reported disease burden can be monitored within the study app via the RAID instrument. Based on random allocation to one of both intervention groups, the RAID will be prompted either weekly (group A) or monthly (group B).
Control Group (Usual Care)
No access to the study app, follow-up according to usual care standards. This includes informal screening for general wellbeing during outpatient clinic visits, with referral to specific allied health professionals for additional education or non-pharmacological support if needed. The scores derived from study-related questionnaires can be used as a guide for these discussions. As part of standard care, participants in both the control group and the intervention groups will also receive a standardised educational leaflet about RA.
Overall Study
Lost to Follow-up
1
1
0

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Combined Intervention Group (A & B)
n=60 Participants
Access to the study app with either weekly or monthly prompts to complete the patient-reported questionnaire Rheumatoid Arthritis Impact of Disease (RAID) Mobile app-based self-management intervention: The self-management program, accessible via a smartphone app, comprises several components. First, the app contains an RA-specific educational program presented as videos in 16 weekly modules. Second, the app provides patients with tailored lifestyle advice, both as part of the educational program and in the form of personalized messages from a certified health coach. Third, the study app includes remote monitoring features underpinned by goal-setting principles. For instance, participants can use the app to log daily steps and physical activity, as well as their diet, sleep, and mental health. Personal goals, as well as physical challenges and meditation or mindfulness exercises, can be set up within the app to encourage behavioral change. Finally, patient-reported disease burden can be monitored within the study app via the RAID instrument. Based on random allocation to one of both intervention groups, the RAID will be prompted either weekly (group A) or monthly (group B).
Control Group (Usual Care)
n=62 Participants
No access to the study app, follow-up according to usual care standards. This includes informal screening for general wellbeing during outpatient clinic visits, with referral to specific allied health professionals for additional education or non-pharmacological support if needed. The scores derived from study-related questionnaires can be used as a guide for these discussions. As part of standard care, participants in both the control group and the intervention groups will also receive a standardised educational leaflet about RA.
Total
n=122 Participants
Total of all reporting groups
Age, Continuous
58 years
STANDARD_DEVIATION 12 • n=60 Participants
58 years
STANDARD_DEVIATION 11 • n=62 Participants
58 years
STANDARD_DEVIATION 12 • n=122 Participants
Sex: Female, Male
Female
38 Participants
n=60 Participants
45 Participants
n=62 Participants
83 Participants
n=122 Participants
Sex: Female, Male
Male
22 Participants
n=60 Participants
17 Participants
n=62 Participants
39 Participants
n=122 Participants
Race and Ethnicity Not Collected
0 Participants
Race and Ethnicity were not collected from any participant.
RF/ACPA positive
43 Participants
n=60 Participants
55 Participants
n=62 Participants
98 Participants
n=122 Participants
Erosive disease
26 Participants
n=60 Participants
27 Participants
n=62 Participants
53 Participants
n=122 Participants
Disease duration, years
11 years
STANDARD_DEVIATION 9 • n=60 Participants
13 years
STANDARD_DEVIATION 10 • n=62 Participants
12 years
STANDARD_DEVIATION 10 • n=122 Participants
BMI
26 kg/m2
STANDARD_DEVIATION 5 • n=60 Participants
27 kg/m2
STANDARD_DEVIATION 5 • n=62 Participants
27 kg/m2
STANDARD_DEVIATION 5 • n=122 Participants
Smoking ever
30 Participants
n=60 Participants
27 Participants
n=62 Participants
57 Participants
n=122 Participants
Rheumatic Disease Comorbidity Index (RDCI)
1.1 units on a scale
STANDARD_DEVIATION 1.4 • n=60 Participants
1.5 units on a scale
STANDARD_DEVIATION 1.5 • n=62 Participants
1.3 units on a scale
STANDARD_DEVIATION 1.5 • n=122 Participants
DAS28-CRP
2.3 units on a scale
STANDARD_DEVIATION 0.9 • n=60 Participants
2.4 units on a scale
STANDARD_DEVIATION 1.0 • n=62 Participants
2.4 units on a scale
STANDARD_DEVIATION 1.0 • n=122 Participants
Health Assessment Questionnaire (HAQ)
0.7 units on a scale
STANDARD_DEVIATION 0.7 • n=60 Participants
0.6 units on a scale
STANDARD_DEVIATION 0.6 • n=62 Participants
0.6 units on a scale
STANDARD_DEVIATION 0.6 • n=122 Participants
Rheumatoid Arthritis Impact of Disease (RAID)
3.6 units on a scale
STANDARD_DEVIATION 2.4 • n=60 Participants
3.7 units on a scale
STANDARD_DEVIATION 2.3 • n=62 Participants
3.7 units on a scale
STANDARD_DEVIATION 2.4 • n=122 Participants
Arthritis Self-Efficacy Scale (ASES)
72 units on a scale
STANDARD_DEVIATION 22 • n=60 Participants
72 units on a scale
STANDARD_DEVIATION 20 • n=62 Participants
72 units on a scale
STANDARD_DEVIATION 22 • n=122 Participants
Pain Catastrophizing Scale (PCS)
13 units on a scale
STANDARD_DEVIATION 11 • n=60 Participants
14 units on a scale
STANDARD_DEVIATION 13 • n=62 Participants
14 units on a scale
STANDARD_DEVIATION 13 • n=122 Participants

PRIMARY outcome

Timeframe: At follow-up visit (4-6 months from baseline)

Superiority outcome. The ASES is a patient-reported questionnaire consisting of 20 items across 2 subscales: self-efficacy for managing pain (range 5-50), and self-efficacy for controlling other symptoms (range 6-60). Both scores can be summed to derive a total ASES-score (range 11-110). Higher scores indicate higher perceived self-efficacy.

Outcome measures

Outcome measures
Measure
Combined Intervention Group (A & B)
n=60 Participants
Access to the study app with either weekly or monthly prompts to complete the patient-reported questionnaire Rheumatoid Arthritis Impact of Disease (RAID) Mobile app-based self-management intervention: The self-management program, accessible via a smartphone app, comprises several components. First, the app contains an RA-specific educational program presented as videos in 16 weekly modules. Second, the app provides patients with tailored lifestyle advice, both as part of the educational program and in the form of personalized messages from a certified health coach. Third, the study app includes remote monitoring features underpinned by goal-setting principles. For instance, participants can use the app to log daily steps and physical activity, as well as their diet, sleep, and mental health. Personal goals, as well as physical challenges and meditation or mindfulness exercises, can be set up within the app to encourage behavioral change. Finally, patient-reported disease burden can be monitored within the study app via the RAID instrument. Based on random allocation to one of both intervention groups, the RAID will be prompted either weekly (group A) or monthly (group B).
Control Group (Usual Care)
n=62 Participants
No access to the study app, follow-up according to usual care standards. This includes informal screening for general wellbeing during outpatient clinic visits, with referral to specific allied health professionals for additional education or non-pharmacological support if needed. The scores derived from study-related questionnaires can be used as a guide for these discussions. As part of standard care, participants in both the control group and the intervention groups will also receive a standardised educational leaflet about RA.
Arthritis Self-Efficacy Scale (ASES)
74 score on a scale
Standard Deviation 22
74 score on a scale
Standard Deviation 20

SECONDARY outcome

Timeframe: At follow-up visit (4-6 months from baseline)

Non-inferiority outcome. The PCS comprises 13 items on a 0-4 Likert scale, resulting in a total score of 0-52 with subscales for rumination, magnification, and helplessness. Higher scores indicate more catastrophic perceptions concerning pain. Additionally, a post-hoc analysis will be carried out comparing the PCS between intervention group A and B, to study the influence of PRO-reporting frequency on pain catastrophising.

Outcome measures

Outcome measures
Measure
Combined Intervention Group (A & B)
n=60 Participants
Access to the study app with either weekly or monthly prompts to complete the patient-reported questionnaire Rheumatoid Arthritis Impact of Disease (RAID) Mobile app-based self-management intervention: The self-management program, accessible via a smartphone app, comprises several components. First, the app contains an RA-specific educational program presented as videos in 16 weekly modules. Second, the app provides patients with tailored lifestyle advice, both as part of the educational program and in the form of personalized messages from a certified health coach. Third, the study app includes remote monitoring features underpinned by goal-setting principles. For instance, participants can use the app to log daily steps and physical activity, as well as their diet, sleep, and mental health. Personal goals, as well as physical challenges and meditation or mindfulness exercises, can be set up within the app to encourage behavioral change. Finally, patient-reported disease burden can be monitored within the study app via the RAID instrument. Based on random allocation to one of both intervention groups, the RAID will be prompted either weekly (group A) or monthly (group B).
Control Group (Usual Care)
n=62 Participants
No access to the study app, follow-up according to usual care standards. This includes informal screening for general wellbeing during outpatient clinic visits, with referral to specific allied health professionals for additional education or non-pharmacological support if needed. The scores derived from study-related questionnaires can be used as a guide for these discussions. As part of standard care, participants in both the control group and the intervention groups will also receive a standardised educational leaflet about RA.
Pain Catastrophizing Scale (PCS)
11 score on a scale
Standard Deviation 8
13 score on a scale
Standard Deviation 10

SECONDARY outcome

Timeframe: At follow-up visit (4-6 months from baseline)

Superiority outcome. The RAID consists of 7 items on a 0-10 numeric rating scale, enquiring about the impact of RA on pain, functional limitations, fatigue, sleep, physical wellbeing, emotional wellbeing, and coping. A total RAID score (0-10) is derived as a weighted average of the 7 subscores (Pain: 21%, Functional disability: 16%, Fatigue: 15%, Emotional well-being: 12%, Sleep: 12%, Coping: 12%, Physical well-being: 12%). Higher scores on both the total scale and the subscales indicate more perceived disease impact.

Outcome measures

Outcome measures
Measure
Combined Intervention Group (A & B)
n=60 Participants
Access to the study app with either weekly or monthly prompts to complete the patient-reported questionnaire Rheumatoid Arthritis Impact of Disease (RAID) Mobile app-based self-management intervention: The self-management program, accessible via a smartphone app, comprises several components. First, the app contains an RA-specific educational program presented as videos in 16 weekly modules. Second, the app provides patients with tailored lifestyle advice, both as part of the educational program and in the form of personalized messages from a certified health coach. Third, the study app includes remote monitoring features underpinned by goal-setting principles. For instance, participants can use the app to log daily steps and physical activity, as well as their diet, sleep, and mental health. Personal goals, as well as physical challenges and meditation or mindfulness exercises, can be set up within the app to encourage behavioral change. Finally, patient-reported disease burden can be monitored within the study app via the RAID instrument. Based on random allocation to one of both intervention groups, the RAID will be prompted either weekly (group A) or monthly (group B).
Control Group (Usual Care)
n=62 Participants
No access to the study app, follow-up according to usual care standards. This includes informal screening for general wellbeing during outpatient clinic visits, with referral to specific allied health professionals for additional education or non-pharmacological support if needed. The scores derived from study-related questionnaires can be used as a guide for these discussions. As part of standard care, participants in both the control group and the intervention groups will also receive a standardised educational leaflet about RA.
Rheumatoid Arthritis Impact of Disease (RAID)
3.6 score on a scale
Standard Deviation 2.4
3.5 score on a scale
Standard Deviation 2.2

SECONDARY outcome

Timeframe: At follow-up visit (4-6 months from baseline)

Superiority outcome. The IPAQ-S is a 7-item questionnaire enquiring about physical activities during the last 7 days. An activity score is obtained for different domains, each multiplied with the accompanying metabolic equivalent of task (MET) value, leading to a sum score corresponding with low, moderate, or high physical activity.

Outcome measures

Outcome measures
Measure
Combined Intervention Group (A & B)
n=60 Participants
Access to the study app with either weekly or monthly prompts to complete the patient-reported questionnaire Rheumatoid Arthritis Impact of Disease (RAID) Mobile app-based self-management intervention: The self-management program, accessible via a smartphone app, comprises several components. First, the app contains an RA-specific educational program presented as videos in 16 weekly modules. Second, the app provides patients with tailored lifestyle advice, both as part of the educational program and in the form of personalized messages from a certified health coach. Third, the study app includes remote monitoring features underpinned by goal-setting principles. For instance, participants can use the app to log daily steps and physical activity, as well as their diet, sleep, and mental health. Personal goals, as well as physical challenges and meditation or mindfulness exercises, can be set up within the app to encourage behavioral change. Finally, patient-reported disease burden can be monitored within the study app via the RAID instrument. Based on random allocation to one of both intervention groups, the RAID will be prompted either weekly (group A) or monthly (group B).
Control Group (Usual Care)
n=62 Participants
No access to the study app, follow-up according to usual care standards. This includes informal screening for general wellbeing during outpatient clinic visits, with referral to specific allied health professionals for additional education or non-pharmacological support if needed. The scores derived from study-related questionnaires can be used as a guide for these discussions. As part of standard care, participants in both the control group and the intervention groups will also receive a standardised educational leaflet about RA.
International Physical Activity Questionnaire Short Form (IPAQ-S)
5036 MET minutes/week
Standard Deviation 3927
4674 MET minutes/week
Standard Deviation 4046

SECONDARY outcome

Timeframe: At follow-up visit (4-6 months from baseline)

Superiority outcome. The PSQI measures sleep quality through 19 items across 7 domains, with a resulting total score ranging from 0-21.Higher scores indicate worse sleep quality.

Outcome measures

Outcome measures
Measure
Combined Intervention Group (A & B)
n=60 Participants
Access to the study app with either weekly or monthly prompts to complete the patient-reported questionnaire Rheumatoid Arthritis Impact of Disease (RAID) Mobile app-based self-management intervention: The self-management program, accessible via a smartphone app, comprises several components. First, the app contains an RA-specific educational program presented as videos in 16 weekly modules. Second, the app provides patients with tailored lifestyle advice, both as part of the educational program and in the form of personalized messages from a certified health coach. Third, the study app includes remote monitoring features underpinned by goal-setting principles. For instance, participants can use the app to log daily steps and physical activity, as well as their diet, sleep, and mental health. Personal goals, as well as physical challenges and meditation or mindfulness exercises, can be set up within the app to encourage behavioral change. Finally, patient-reported disease burden can be monitored within the study app via the RAID instrument. Based on random allocation to one of both intervention groups, the RAID will be prompted either weekly (group A) or monthly (group B).
Control Group (Usual Care)
n=62 Participants
No access to the study app, follow-up according to usual care standards. This includes informal screening for general wellbeing during outpatient clinic visits, with referral to specific allied health professionals for additional education or non-pharmacological support if needed. The scores derived from study-related questionnaires can be used as a guide for these discussions. As part of standard care, participants in both the control group and the intervention groups will also receive a standardised educational leaflet about RA.
Pittsburgh Sleep Quality Index (PSQI)
7.5 score on a scale
Standard Deviation 3.9
8.0 score on a scale
Standard Deviation 3.6

OTHER_PRE_SPECIFIED outcome

Timeframe: Throughout study period (intervention arms only): 4-6 months. Specifically, these data will be collected at the follow-up visit (4-6 months from baseline) and reported for the whole study period.

The proportion of in-app completed RAID questionnaires will be calculated as the ratio (%) between completed questionnaires and the total number of questionnaires that were prompted throughout the study period.

Outcome measures

Outcome measures
Measure
Combined Intervention Group (A & B)
n=30 Participants
Access to the study app with either weekly or monthly prompts to complete the patient-reported questionnaire Rheumatoid Arthritis Impact of Disease (RAID) Mobile app-based self-management intervention: The self-management program, accessible via a smartphone app, comprises several components. First, the app contains an RA-specific educational program presented as videos in 16 weekly modules. Second, the app provides patients with tailored lifestyle advice, both as part of the educational program and in the form of personalized messages from a certified health coach. Third, the study app includes remote monitoring features underpinned by goal-setting principles. For instance, participants can use the app to log daily steps and physical activity, as well as their diet, sleep, and mental health. Personal goals, as well as physical challenges and meditation or mindfulness exercises, can be set up within the app to encourage behavioral change. Finally, patient-reported disease burden can be monitored within the study app via the RAID instrument. Based on random allocation to one of both intervention groups, the RAID will be prompted either weekly (group A) or monthly (group B).
Control Group (Usual Care)
n=30 Participants
No access to the study app, follow-up according to usual care standards. This includes informal screening for general wellbeing during outpatient clinic visits, with referral to specific allied health professionals for additional education or non-pharmacological support if needed. The scores derived from study-related questionnaires can be used as a guide for these discussions. As part of standard care, participants in both the control group and the intervention groups will also receive a standardised educational leaflet about RA.
Participant Engagement With Study Application: Remote Monitoring of RAID
47 percentage completed RAIDs
53 percentage completed RAIDs

OTHER_PRE_SPECIFIED outcome

Timeframe: Throughout study period (intervention arms only): 4-6 months. Specifically, these data will be collected at the follow-up visit (4-6 months from baseline) and reported for the whole study period.

Usage data will be logged passively in the study app. Usage data consist of information concerning how often the app and its core functions are accessed. Specifically, we will calculate the proportion of days where the study app was accessed, and the proportion of days where an educational video was viewed within the study app.

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: Throughout study period (intervention arms only): 4-6 months. Specifically, these data will be collected at the follow-up visit (4-6 months from baseline) and reported for the whole study period.

When users choose to activate this function, the number of steps per day will also be passively logged in the study app. When available, we will analyze daily step patterns descriptively (proportion meeting the WHO-recommended daily target, evolution over time, correlation with IPAQ-S score, and correlation with symptoms based on the RAID).

Outcome measures

Outcome data not reported

Adverse Events

Intervention Group A (Weekly RAID)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Intervention Group B (Monthly RAID)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Control Group (Usual Care)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Patrick Verschueren

UZ Leuven

Phone: 003216342541

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place